MARK ELIJAH FANKHAUSER
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner EDINBURG, TX NPI 1841906005
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner TX Medtronic, Inc. All categories
General Payments — all program years on this page
$5,658.40
- Category: General Payments
- Program years: PY2022–2024
- Record count: 189
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $3,880.92 across 126 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $3,052.02 | 122 |
| Travel and Lodging | $817.61 | 3 |
| Education | $11.29 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $1,275.42 | 12 |
| DEXCOM, INC. | $409.69 | 15 |
| Corcept Therapeutics | $367.07 | 20 |
| Novo Nordisk AS | $317.58 | 11 |
| Insulet Corporation | $266.01 | 6 |
| Lilly USA, LLC | $205.31 | 14 |
| Tandem Diabetes Care, Inc. | $152.71 | 2 |
| MannKind Corporation | $149.62 | 9 |
| Radius Health, Inc. | $148.23 | 8 |
| Amgen Inc. | $139.68 | 10 |
| Ascensia Diabetes Care US Inc. | $115.59 | 1 |
| Xeris Pharmaceuticals, Inc. | $94.11 | 5 |
| Averitas Pharma Inc. | $86.21 | 4 |
| RECORDATI_RARE_DISEASES_INC. | $42.70 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $42.05 | 2 |
| Antares Pharma, Inc. | $27.67 | 2 |
| Astellas Pharma US Inc | $20.16 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.77 | 1 |
| CeQur Corporation | $1.34 | 1 |
By program year
Records — PY2024 (126)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.